COMMUNIQUÉS West-GlobeNewswire

Beleave Receives Notification of Pre-Sale Inspection Date
31/01/2018
TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Beleave Inc. (" Beleave " or the " Company ") (CSE:BE)(OTCQX:BLEVF) is pleased to announce that it has received notification from Health Canada that the Company's pre-sale [...]
Oncolix Sponsors Additional Research with MD Anderson Cancer Center
31/01/2018
HOUSTON, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Oncolix, Inc., (OTCQB:ONCX) announced today that the Company has sponsored additional research with MD Anderson Cancer Center. The research will evaluate Prolanta TM for the [...]
KemPharm to Present at The MoneyShow Orlando Investor Conference
31/01/2018
CORALVILLE, Iowa, Jan. 31, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (Nasdaq: KMPH ), a clinical-stage specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today [...]
GTX Corp Silver Sponsor at Super Bowl LII Big Game Experience Showcasing New Line of Biometric Insoles at Gifting Suite
31/01/2018
LOS ANGELES, Jan. 31, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO ) , an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive technology business, announced today [...]
Innovate Biopharmaceuticals Announces Trading Under New Ticker Symbol INNT is Anticipated to Begin on Thursday, February 1, 2018
31/01/2018
RALEIGH, N.C., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT ), a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, announced [...]
Protalix BioTherapeutics’ pegunigalsidase alfa Receives Fast Track Designation from the U.S. Food and Drug Administration
31/01/2018
CARMIEL, Israel, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE: PLX ), announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to [...]
ESPERITE (ESP) and BGI Genomics (BGI) sign a strategic agreement to offer Whole Genome Sequencing on a large scale.
31/01/2018
Esperite with BGI sequencing technology will enable the global population easier access to the gold standard in clinical genetic testing. Amsterdam, The Netherlands - 31 January 2018 BGI is the world's genome sequencing [...]
Published Study Demonstrates the Association Between Immunovaccine’s Proprietary Immune-targeted Delivery Technology and Enhanced Efficacy in Slowing Tumor Progression
31/01/2018
HALIFAX, Nova Scotia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced the publication of a preclinical study using magnetic [...]
Allergy Therapeutics: Trading Update
31/01/2018
Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group") Trading Update Market share gains driving top line growth Strong cash position sustained by good performance. 31 January 2017 Allergy Therapeutics plc ( [...]
Microbot Medical Inc. to Initiate Townhall Meetings
31/01/2018
HINGHAM, Mass., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT ), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today [...]
Cara Therapeutics Initiates Pivotal Phase 3 Efficacy Trial of KORSUVA™ (CR845/difelikefalin) Injection in Hemodialysis Patients with Chronic Kidney Disease-Associated Pruritus
31/01/2018
STAMFORD, Conn., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA ), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and [...]
Revive Therapeutics Submits Cannabinoid Delivery Technology Findings Abstract for 29th International Conference on Polyphenols and the 9th Tannin Conference
31/01/2018
TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive " or the " Company ") (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel [...]
MediciNova Announces Presentation of the SPRINT-MS Phase 2b Study of MN-166 (ibudilast) in Progressive MS at the ACTRIMS Forum on February 1, 2018 in San Diego
31/01/2018
LA JOLLA, Calif., Jan. 31, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
Clementia Appoints Industry Veteran Pierre Legault to its Board of Directors
31/01/2018
MONTREAL, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ: CMTA ), a clinical-stage biopharmaceutical company innovating new treatments for people with ultra-rare bone disorders and other [...]
Clementia nomme Pierre Legault, un vétéran de l’industrie, au sein de son conseil d’administration
31/01/2018
MONTRÉAL, 31 janv. 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ: CMTA ), une société biopharmaceutique au stade clinique proposant des traitements novateurs pour les personnes atteintes de troubles [...]
Novo Nordisk A/S - Share repurchase programme
31/01/2018
Bagsværd, Denmark, 31 January 2018 - On 1 November 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]
BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Esophageal Squamous Cell Carcinoma
31/01/2018
CAMBRIDGE, Mass. and BEIJING, China, Jan. 31, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]
Green Cures & Botanical Distribution Inc. Begins Building E-Commerce Site, Working on New Packaging, and Developing New Products
31/01/2018
LOS ANGELES, CA, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Green Cures and Botanical Distribution Inc. (OTC PINK: GRCU), an innovative hemp-infused nutrition, botanical, sports, and body care products company, has engaged a web [...]
Results from 31 January 2018 General Meeting
31/01/2018
MELBOURNE, Australia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE ) (“Company”) advises that a General Meeting of shareholders that had been requisitioned pursuant to section [...]

Pages